Parallel Advisors’s Cardlytics CDLX Stock Holding History

Parallel Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3	Closed	-$249	–	3315
2023 Q4	$249	Buy	+3	New	+$305	﹤0.01%	3145
2023 Q1	–	Sell	-23	Closed	-$1.32K	–	3428
2022 Q4	$1.32K	Buy	23 +20	+667%	+$1.24K	﹤0.01%	2820
2022 Q3	$0	Sell	3 -12	-80%	-$1.71K	﹤0.01%	3173
2022 Q2	$3K	Buy	15 +14	+1,400%	+$4.69K	﹤0.01%	2427
2022 Q1	$0	Sell	1 -1	-50%	-$604	﹤0.01%	2998
2021 Q4	$1K	Buy	+2	New	+$1.53K	﹤0.01%	2841
2021 Q2	–	Sell	-1	Closed	-$1K	–	2943
2021 Q1	$1K	Buy	+1	New	+$1.32K	﹤0.01%	2588

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Parallel Advisors's CDLX Position: Q1 2024 in Review

Parallel Advisors sold out of Cardlytics (CDLX) in Q1 2024, closing a stake of 3 shares — an estimated $249 sold.

Parallel Advisors first reported a position in CDLX in Q1 2021 and held it in 7 quarters. The position peaked at $3K in Q2 2022. 144 funds tracked by Wall St. Rank hold CDLX as of Q1 2024.

Parallel Advisors reported no remaining Cardlytics position as of Q1 2024 after selling out during the quarter.
Parallel Advisors sold 3 Cardlytics shares in Q1 2024, an estimated $249.
Parallel Advisors first reported a position in Cardlytics in Q1 2021 and held it in 7 quarters.
Parallel Advisors's Cardlytics position peaked at $3K in Q2 2022.
144 funds tracked by Wall St. Rank held Cardlytics as of Q1 2024.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.